Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PDS Biotechnology Corporation - Common Stock (NQ:PDSB)

0.9200 -0.0300 (-3.16%)
Streaming Delayed Price Updated: 9:43 AM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 178,716
Open 0.9500
Bid (Size) 0.9200 (7)
Ask (Size) 0.9436 (1)
Prev. Close 0.9500
Today's Range 0.9000 - 0.9500
52wk Range 0.8505 - 3.440
Shares Outstanding 28,458,688
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
PDS Biotechnology Stock Logs Best Session In 2 Months After FDA Fast-Track Push For Cancer Drug — Retail Bets On Early Approval
The company requested a meeting with the FDA to discuss an accelerated approval pathway for its lead cancer drug, PDS0101, following strong final data from its VERSATILE-002 trial. 
Via Stocktwits
Align Technology Stock Surges After-Hours On Teen Demand — Retail Sees Rally Ahead Into 2026
Q3 revenue of $995.7 million beat Align’s own forecast range of $965 million to $985 million, fueled by strong growth in clear aligners for teens and kids. 
Via Stocktwits

Performance

YTD
-46.8%
-46.8%
1 Month
-8.9%
-8.9%
3 Month
-14.0%
-14.0%
6 Month
-30.8%
-30.8%
1 Year
-71.4%
-71.4%

More News

Read More
PDS BIOTECHNOLOGY CORP (NASDAQ:PDSB) Reports Narrower Q2 2025 Loss, Stock Rises on Clinical Progress
Via Chartmill
PDSB Loss Improves as Costs Drop
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Insights Ahead: PDS Biotechnology's Quarterly Earnings
Via Benzinga
A Look at PDS Biotechnology's Upcoming Earnings Report
Via Benzinga
Earnings Scheduled For August 13, 2025
Via Benzinga
Insights into PDS Biotechnology's Upcoming Earnings
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
PDS Biotechnology Stock In Spotlight On Better-Than-Feared 2024 Loss – Retail Stays Bearish
Via Stocktwits
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
Uncovering Potential: PDS Biotechnology's Earnings Preview
Via Benzinga
Earnings Preview For PDS Biotechnology
Via Benzinga
Earnings Scheduled For May 14, 2025
Via Benzinga
Earnings Scheduled For March 27, 2025
Via Benzinga
Life Sciences Investor Forum Agenda Announced for March 13th
From Virtual Investor Conferences
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
PDSB Stock Earnings: PDS Biotechnology Beats EPS for Q2 2024
Via InvestorPlace
PDSB Stock Earnings: PDS Biotechnology Beats EPS for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
PDSB Stock Earnings: PDS Biotechnology Beats EPS for Q4 2023
Via InvestorPlace
Earnings Scheduled For November 14, 2024
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 27, 2024
Via Benzinga

Frequently Asked Questions

Is PDS Biotechnology Corporation - Common Stock publicly traded?
Yes, PDS Biotechnology Corporation - Common Stock is publicly traded.
What exchange does PDS Biotechnology Corporation - Common Stock trade on?
PDS Biotechnology Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for PDS Biotechnology Corporation - Common Stock?
The ticker symbol for PDS Biotechnology Corporation - Common Stock is PDSB on the Nasdaq Stock Market
What is the current price of PDS Biotechnology Corporation - Common Stock?
The current price of PDS Biotechnology Corporation - Common Stock is 0.9200
When was PDS Biotechnology Corporation - Common Stock last traded?
The last trade of PDS Biotechnology Corporation - Common Stock was at 10/31/25 09:43 AM ET
What is the market capitalization of PDS Biotechnology Corporation - Common Stock?
The market capitalization of PDS Biotechnology Corporation - Common Stock is 26.18M
How many shares of PDS Biotechnology Corporation - Common Stock are outstanding?
PDS Biotechnology Corporation - Common Stock has 26M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.